These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14210646)

  • 1. [SELECTIVE SYMPATHICOLYSIS AND MYOCARDIAL FUNCTION].
    HAAS H
    Dtsch Med Wochenschr; 1964 Nov; 89():2117-21. PubMed ID: 14210646
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on coronary-active substances].
    Haas H
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1299+. PubMed ID: 5536555
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on coronary-active substances].
    Haas H
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1295+. PubMed ID: 5536554
    [No Abstract]   [Full Text] [Related]  

  • 4. [Selective inhibition of myocardial contractility by competitive divalent Ca++ antagonists (iproveratril, D 600, prenylamine)].
    Fleckenstein A; Tritthart H; Fleckenstein B; Herbst A; Grün G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):227-8. PubMed ID: 4242380
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the action mechanism of new coronary dilators with simultaneous oxygen saving myocardial effects, Prenylamine and Iproveratril. 1].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Jul; 56(7):716-44. PubMed ID: 5592004
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of coronary circulatory disorders in internal practice with segontin].
    HAMANN E
    Landarzt; 1961 Nov; 37():1277-9. PubMed ID: 13904049
    [No Abstract]   [Full Text] [Related]  

  • 7. [A double-blind experiment with the coronary therapeutic agent segontin].
    OVERKAMP H
    Med Klin; 1960 Aug; 55():1423-6. PubMed ID: 14429518
    [No Abstract]   [Full Text] [Related]  

  • 8. EVALUATION OF "CORONARY VASODILATORS" BY CORONARY ARTERIOGRAPHY.
    LIKOFF W; KASPARIAN H; LEHMAN JS; SEGAL BL
    Am J Cardiol; 1964 Jan; 13():7-9. PubMed ID: 14103193
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experiences with the clinical use of Segontin in coronary disease].
    OHIRA I; HAGIWARA M; UMEZONO T; TSUCHIYA T; IMAGAWA S; MATSUOKA K
    Chiryo; 1962 Aug; 44():1573-7. PubMed ID: 14481363
    [No Abstract]   [Full Text] [Related]  

  • 10. [CLINICO-PHARMACOLOGICAL STUDIES WITH CORONTIN, A NEW CORONARY VASODILATOR AGENT].
    VOTCSAL BE; VISZOKIJ FF
    Orv Hetil; 1965 May; 106():975-8. PubMed ID: 14309163
    [No Abstract]   [Full Text] [Related]  

  • 11. [The treatment of coronary infarct with high doses of 1-benzyl-3-ethyl-6,7-dimethoxyisoquinoline hydrochloride as well as the use of vasodilator substances in acute coronary occlusion].
    VOELKER R
    Arzneimittelforschung; 1962 Mar; 12():299-302. PubMed ID: 13926394
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical experiences with segontin].
    RATSCHOW M; SCHOOP W
    Med Klin; 1960 Aug; 55():1421-3. PubMed ID: 14436429
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the method of action of new types of coronary dilatators with simultaneous oxygen-saving myocardial effects, prenylamine and iproveratril. 2].
    Fleckenstein A; Kammermeier H; Döring HJ; Freund HJ
    Z Kreislaufforsch; 1967 Aug; 56(8):839-58. PubMed ID: 5592708
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experiences with segontin in internal medical practice].
    MENZEL M
    Ther Ggw; 1960 Sep; 99():432-4. PubMed ID: 13769511
    [No Abstract]   [Full Text] [Related]  

  • 15. [Limitation of the disappearance of energy-rich phosphate compounds in the hyperactive atrial and ventricular myocardium by divalent Ca-antagonistic inhibitors of electromechanical coupling (iprovdratril, D 600, prenylamine)].
    Doring HJ; Leder O; Jaedicke W; Reindell A; Fleckenstein A
    Pflugers Arch; 1969; 312(1):R7-8. PubMed ID: 5390299
    [No Abstract]   [Full Text] [Related]  

  • 16. [3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
    DELLA PORTA P; LUCCHINI CR
    Minerva Cardioangiol; 1961 Sep; 9():533-6. PubMed ID: 13885183
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of anti-anginal drugs on AV-conduction in normal subjects.
    Neuss H; Nowak FG; Schlepper M; Wüsten B
    Arzneimittelforschung; 1974 Feb; 24(2):213-6. PubMed ID: 4150916
    [No Abstract]   [Full Text] [Related]  

  • 18. [CHEMISTRY OF CARDIAC DRUGS].
    KNABE J
    Med Monatsschr; 1964 Feb; 18():54-8. PubMed ID: 14165991
    [No Abstract]   [Full Text] [Related]  

  • 19. [Sympatholytic ("antisympathotonic") substances].
    Kruger K
    Minerva Med; 1968 Dec; 59(96):5227-30. PubMed ID: 5710726
    [No Abstract]   [Full Text] [Related]  

  • 20. [Protective effect of organic Ca antagonists (iproveratril, D 600, prenylamine) against isoproterenol-induced myocardial necrosis].
    Leder O; Döring HJ; Reindell A; Fleckenstein A
    Pflugers Arch; 1969; 312(1):R9-10. PubMed ID: 5390319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.